USA Herald August 19, 2026
Moderna and Merck Cancer Vaccine Meets Phase 3 Goals in Melanoma Trial
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
USA Herald August 19, 2026
The Moderna and Merck cancer vaccine has met the main goals of a large Phase 3 melanoma trial, marking a…
By David Akinwale
America June 12, 2025
In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…
By Rihem Akkouche
Science & Technology August 2, 2021
The United States has announced the launch of a new program for Covi-19 booster shots. According to health officials in…
By Rochdi Rais

